These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 9182143)
21. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Laupland KB; Kirkpatrick AW; Delaney A Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465 [TBL] [Abstract][Full Text] [Related]
22. [Distribution of IgG subclasses and their biological activity in bioglobulin]. Bucholc B; Banach W Med Dosw Mikrobiol; 1998; 50(1-2):105-13. PubMed ID: 9857620 [TBL] [Abstract][Full Text] [Related]
23. Intravenous gamma globulin as adjunct therapy for severe group B streptococcal disease in the newborn. Friedman CA; Wender DF; Temple DM; Rawson JE Am J Perinatol; 1990 Jan; 7(1):1-4. PubMed ID: 2104748 [TBL] [Abstract][Full Text] [Related]
24. [Evaluation of antitoxin and antibacterial activity of human preparations of normal immunoglobulin. I. Level of tetanus antitoxin in preparations of IMIG and IVIG]. Zakrzewska A; Rymkiewicz D Przegl Epidemiol; 1995; 49(4):381-4. PubMed ID: 8868196 [TBL] [Abstract][Full Text] [Related]
25. [Therapeutic effectiveness of an intravenous immunoglobulin with pH 4.25 in experimental neonatal sepsis caused by Klebsiella pneumoniae]. Mancilla-Ramírez J; Nurko-Shein S; Castellanos-Cruz C; Santos-Preciado JI Bol Med Hosp Infant Mex; 1989 Feb; 46(2):89-93. PubMed ID: 2496700 [TBL] [Abstract][Full Text] [Related]
26. Enhanced effects of amoxycillin/clavulanic acid compared with amoxycillin and clavulanic acid alone on the susceptibility to immunodefenses of a penicillin-resistant strain of Streptococcus pneumoniae. Cuffini AM; Tullio V; Ianni Palarchio A; Bonino A; Paizis G; Carlone NA Drugs Exp Clin Res; 1998; 24(4):173-84. PubMed ID: 10051963 [TBL] [Abstract][Full Text] [Related]
27. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery. Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247 [TBL] [Abstract][Full Text] [Related]
28. [Ampicillin and combination penicillins in clinical medicine (antibacterial effects)]. Metz H Munch Med Wochenschr; 1972 Sep; 114(35):1515-9. PubMed ID: 4628080 [No Abstract] [Full Text] [Related]
29. High intravenous doses of human immune globulin suppress neonatal group B streptococcal immunity in rats. Weisman LE; Lorenzetti PM J Pediatr; 1989 Sep; 115(3):445-50. PubMed ID: 2671331 [TBL] [Abstract][Full Text] [Related]
30. Antibiotic use in neonatal sepsis. Yurdakök M Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468 [TBL] [Abstract][Full Text] [Related]
31. Behaviour of serum immunoglobulins during and after intravenous administration of gamma-globulins in patients with antibody deficiency syndrome. Gravina E; Gravina-Sanvitale G Boll Ist Sieroter Milan; 1974; 53(1):suppl:268. PubMed ID: 4136556 [No Abstract] [Full Text] [Related]
32. Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes. Reagan WJ; Scott-Moncrieff C; Christian J; Snyder P; Kelly K; Glickman L Am J Vet Res; 1998 Dec; 59(12):1568-74. PubMed ID: 9858408 [TBL] [Abstract][Full Text] [Related]
33. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Jacobs BC; O'Hanlon GM; Bullens RW; Veitch J; Plomp JJ; Willison HJ Brain; 2003 Oct; 126(Pt 10):2220-34. PubMed ID: 12876146 [TBL] [Abstract][Full Text] [Related]
34. Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulin. Lassiter HA; Speranza MJ; Hall RT; Meade V; Christensen RD; Parker CJ J Perinatol; 1990 Mar; 10(1):27-31. PubMed ID: 2107285 [TBL] [Abstract][Full Text] [Related]
35. Effect of intravenous immunoglobulin G on the deposition of immunoglobulin G and C3 onto type III group B streptococcus and Escherichia coli K1. Lassiter HA; Robinson TW; Brown MS; Hall DC; Hill HR; Christensen RD J Perinatol; 1996; 16(5):346-51. PubMed ID: 8915932 [TBL] [Abstract][Full Text] [Related]
36. Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study. Letko E; Bhol K; Foster SC; Ahmed RA Curr Eye Res; 2000 Aug; 21(2):646-54. PubMed ID: 11148601 [TBL] [Abstract][Full Text] [Related]
37. Stability and activity of intravenous immunoglobulin with neonatal dextrose and total parenteral nutrient solutions. Lindsay CA; Dang K; Adams JM; Ou CN; Baker CJ Ann Pharmacother; 1994 Sep; 28(9):1014-7. PubMed ID: 7803872 [TBL] [Abstract][Full Text] [Related]
38. [Content of IgE in preparations of human immunoglobulin for intravenous use (IVIG)]. Bucholc B; Banach W Med Dosw Mikrobiol; 1993; 45(4):517-21. PubMed ID: 8189833 [TBL] [Abstract][Full Text] [Related]
39. [Effect of Bioglobulin on the clinical course of selected diseases of viral and bacterial etiologies]. Janeczko J; Olejnik Z; Lipowski D; Przyjałkowski W; Romanowska B Przegl Epidemiol; 1991; 45(4):273-7. PubMed ID: 1841402 [TBL] [Abstract][Full Text] [Related]
40. Dose-related protective efficacy of immunoglobulins in experimentally induced group B streptococcal infection. Iguchi K; Inoue S Acta Paediatr Jpn; 1994 Feb; 36(1):25-9. PubMed ID: 8165904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]